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Abstract
Background: The impact of L-arginine on atherogenesis and its ability to prevent endothelial
dysfunction have been studied extensively during the past years. L-arginine is a substance for nitric
oxide synthesis which involves in apoptosis. Hypercholesterolemia promotes endothelial
dysfunction, and it is hypothesized that L-arginine prevents endothelial dysfunction through
endothelial cells apoptosis inhibition. To test this hypothesis, thirty rabbits were assigned into two
groups. The control group received 1% cholesterol diet for 4 weeks, and the L-arginine group
received same diets plus 3% L-arginine in drinking water.
Results: No significant differences were observed in cholesterol level between two groups, but
the nitrite concentration in L-arginine group was significantly higher than other group (control
group: 11.8 ± 1; L-arginine group: 14.7 ± 0.5 μmol/l); (p < 0.05). The aorta score of fatty streak in
control group was 0.875 ± 0.35, but no fatty streak lesion was detected in L-arginine group (p <
0.05). The number of intimal apoptotic cells/500 cells of aorta in two groups of experiment were
statistically different (control group: 39.3 ± 7.6; L-arginine group: 21.5 ± 5.3) (p < 0.05).
Conclusion:  The inhibition of endothelial cells apoptosis by L-arginine restores endothelial
function in a model of hypercholesterolemia.
Background
The concept of programmed cell death was introduced to
describe cell death during normal development [1], and
apoptosis is the most common form of cell death. Apop-
tosis is characterized by cell shrinkage, nuclear fragmenta-
tion and membrane blabbing [2,3].
Atherosclerotic lesions develop in the tunica intima of the
arteries, in which accumulation of cellular components,
lipids, and extracellular matrix yields a fibro fatty plaque
that focally thickens the artery wall [4]. Apoptosis is a fea-
ture of human atherosclerosis which is associated with
development of the lesion necrotic core as well as instabil-
ity of complex plaques [4-9].
The first evidence that endothelial cell (EC) apoptosis
might contribute to the initiation of atherogenesis came
from the observation that all classical risk factors known
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to promote endothelial dysfunction (ED) and atherogen-
esis can induce vascular cell apoptosis [10]. However,
there is some in vivo evidence for a pro-atherogenic effect
of apoptosis. A study in monkeys revealed that vascular
ED was present without evidence of atherosclerosis,
which may be due to endothelial apoptosis [11]. Apop-
totic vascular cells are also found in hypercholesterolemic
pigs and mice [12]. On the other hand, shear stress leads
to physiologic low concentrations of nitric oxide (NO)
within ECs [13]. The continuous generation of NO can
prevent ECs apoptosis, thereby protecting the endothelial
monolayer from injury [14]. Intervention with NO donor;
L-arginine, has induced beneficial effects on atherosclero-
sis [15]. These findings strongly support the current clini-
cal concept that ED precedes plaque formation and
disease progression in patients [16].
The role of L-arginine and NO in apoptosis have been
studied in different conditions (17–30). NO has also been
demonstrated to be involved in the regulation of apopto-
sis, and recent evidence indicates that NO is a potent
modulator of homeostasis operationally preventing or
inducing apoptosis [31,32]. It is also reported that in
some cell types, NO can promote apoptosis, whereas in
others it inhibits apoptosis [33]. L-arginine as a NO donor
is a potent substance to reverse ED [34-37]. Otsuji et al.
studied the relationship between L-arginine and the pro-
gression of atherosclerosis. They found that exogenous L-
arginine reverses acetylcholine-induced vasoconstriction
in human coronary arteries in the early stages of athero-
sclerosis [38]. In hypercholesterolaemic rabbits treated
with L-arginine, platelet aggregation, myointimal cell pro-
liferation and vascular monocyte accumulation were
attenuated while endothelium dependent vasoreactivity
was improved [39]. Therefore, it is a hypothesized that L-
arginine prevents ED through EC apoptosis inhibition in
a model of hypercholesterolemia, and this hypothesis was
tested in this study.
Results
Cholesterol and Nitrite Concentrations
The data for the cholesterol and nitrite concentrations are
tabulated in table 1. The statistical analyses indicate that
no significant difference was observed between the cho-
lesterol levels of two groups, but the nitrite concentration
in L-arginine group was significantly higher than control
group (p < 0.05).
Fatty streak formation
The score of aorta fatty streak in first group was 0.875 ±
0.35, but no fatty streak lesion was detected in L-arginine
group. The statistical analysis indicates that fatty streak
formation is significantly lower in L-arginine group (p <
0.05).
The number of intimal apoptotic cells
The number of intimal apoptotic cells/500 cells in rabbit's
aortas is demonstrated in figure 1 (control group: 39.3 ±
7.6, L-arginine group: 21.5 ± 5.3) (p < 0.05). In situ detec-
tion of apoptotic cells indicate that in aorta section from
control group, the apoptosis of intimal cells is a promi-
nent feature of atherosclerotic lesions, but less apoptosis
cells were observed in L-arginine group (figure 2).
Discussion
The role of L-arginine in ED prevention through EC apop-
tosis inhibition was the main objective of this study. There
was no fatty streak in the aorta of L-arginine treated group
while significant fatty streak lesions were found in control
group. Subsequently, L-arginine supplementation suc-
cessfully prevented atherosclerosis process, and this is in
agreement with the results of several other studies in
which L-arginine supplementation restores endothelial
function [40-47].
Among the NO metabolites, nitrite is a major oxidative
metabolite, which was implicated to be both an indicator
for NO synthase (NOS) activity [48,49] and a circulating
NO donor [50]. It has been shown that up to 70–90% of
plasma nitrite derived from eNOS activity in fasted
humans and other mammals [49,50].
The assumption of L-arginine efficacy theoretically has
been based on eNOS activation and nitrite production
enhancement. Our results were in line of this assumption,
in which L-arginine supplementation led to significantly
higher plasma nitrite concentration. Other studies have
reported NO metabolites increasing in hypercholestero-
lemic animals [51-53]. Although decreased NO bioactiv-
ity (stems from flow mediated dilation studies) has been
Table 1: The mean of serum cholesterol, LDL and nitrite levels in two groups of experiments.
group cholesterol (mg/dl) nitrite (μmol/l)
before after before after
Control (n = 16) 111.7 ± 14.1 2129.1 ± 176.2 10 ± 0.7 11.8 ± 1
L-arginine (n = 14) 125.4 ± 14.5 2109.1 ± 166.9 11.6 ± 0.5 14.7 ± 0.5
p >0.05 >0.05 >0.05 <0.05Lipids in Health and Disease 2008, 7:27 http://www.lipidworld.com/content/7/1/27
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attributed to ED [54], increased plasma level of nitrite has
been reported in hypercholesterolemic patients too [55].
It has been suggested that enhanced NO synthesis might
be a defense mechanism to compensate continuous inac-
tivation of NO and to protect from damaging factors such
as hypercholesterolemia [56,57]. Another proposed
mechanism for the elevation of nitrite may be NO produc-
tion by other isoforms of NOS enzymes [57,58]. Although
decreased activity of eNOS has been indicated in athero-
sclerosis but NO may be produced by iNOS in macro-
phages and other cell types in the atherosclerosis [57,58].
NO is also an essential signaling molecule for endothelial
integrity and growth [59]. A moderate basal NO produc-
tion can protect ECs from damaging effects of risk factor
[49]. We hypothesized that if intrinsic protective mecha-
nisms could be activated by moderate NO production in
ECs, these cells could be better prepared to the ensuing
risk factor (hypercholesterolemia) assault. Our results cor-
roborate the protective role as the L-arginine group had
significantly lower apoptotic cells in aorta intimal layer
after 4 weeks of diet consumption. The precise mecha-
nism responsible for inhibition of apoptosis by NO is not
clear. Several possibilities exist that may explain the anti-
apoptotic effects of NO. NO has been shown to increase
Bcl-2, thioredoxin, and heat-shock protein-70 and -32
expression, and therefore it inhibits the release of mito-
chondrial cytochrome c and apoptosis inducing factors
[33,60,61]. The activation of cGMP and cGMP-dependent
protein kinase by NO increases a major intracellular anti-
apoptotic protein, both directly and indirectly [62].
Also, it has been shown that NO inhibits the caspases-3
and 8 activations in L-arginine treated ECs and conse-
quently inhibits apoptosis, which is consistent with our
findings [63-65]. It should be further acknowledged, how-
ever, that the protective effect of L-arginine could also be
mediated through non-eNOS-dependent pathways, since
L-arginine has anti oxidant effects too [66,67]. Of course
more studies are warranted in this field, and for future
researches, using different doses of L-arginine and choles-
terol diet in acute and chronic models of hypercholester-
olemia are suggested.
Conclusion
L-arginine attenuates the number of apoptosis cells in the
aorta of a model of hypercholesterolemia. The inhibition
of EC apoptosis may be the underlying mechanism of
restore endothelial function by L-arginine.
Methods
Animals and Experimental design
This study was reviewed and approved by the Ethics Com-
mittee of Isfahan University of Medical Sciences. Thirty
white male rabbits weighing 1.95 ± 0.25 kg were obtained
from the Pasteur Institute of Iran. All animals were housed
three per cage with free access to food and water. After 1-
week acclimation period and an overnight fasting, blood
samples were taken as pre-experimental sampling to
obtain baseline data. Collected blood samples were cen-
trifuged (10,000 _ g), and the resulting serum was stored
at -70°C until measurements. The animals were then ran-
domly assigned to 2 groups. The rabbits were fed rabbit
chow supplemented with 1% cholesterol (hypercholeste-
rolemic diet; control group, n = 16) or high-cholesterol
diet with oral L-arginine (3% in drinking water) (L-
arginine group, n = 14) for 4 weeks. Pure cholesterol and
L-arginine were obtained from Scharlau Chemie (Barce-
lona, Spain) and Ajinomoto Co (Japan) respectively. At
the end of experiment, fasting blood samplings were
The intimal apoptotic cells in rabbit's aortas in two groups of  animals Figure 1
The intimal apoptotic cells in rabbit's aortas in two groups of 
animals. Figure shows that less apoptosis cells were observed 
in the aorta of L-arginine group. I Indicate significant differ-
ence from control group (p < 0.05).
TUNEL performed in rabbit's aorta Figure 2
TUNEL performed in rabbit's aorta. Aorta section from rab-
bit that apoptosis of arterial cells is a prominent feature of 
atherosclerotic lesions (control group), but less apoptotic 
cells were observed in the aorta of L-arginine group.Lipids in Health and Disease 2008, 7:27 http://www.lipidworld.com/content/7/1/27
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obtained, and half of the animals of each group randomly
were selected and euthanized by an overdose of sodium
pentobarbital (50 mg/kg) and ex-sanguinated. The ani-
mal's aortas were harvested for pathological investigation.
The serum levels of cholesterol, and nitrite were meas-
ured. The fatty streak formation and the number of apop-
totic cells also were determined as previously described
[53,68,2,3].
Serum cholesterol and nitrite measurements
Total cholesterol level was measured using standard enzy-
matic kit (Pars Azmoon Co, Iran). The serum level of
nitrite (stable NO metabolite) was measured using a
colorimetric assay kit (R&D Systems, Minneapolis, USA)
that involves the Griess reaction. Briefly, serums were
added into wells (96-well enzymatic assay plate). A sulph-
anilamide solution was added to all experimental sam-
ples, and after incubation, N-1-naphtylethylenediamine
dihydrochloride solution was added. Then, absorbance
was measured by a microreader in 540 nm wavelength.
The samples nitrite concentration was determined by
comparison to nitrite standard reference curve. The detec-
tion limit was 0.25 μM nitrite.
Fatty streak determination
The abdominal aortas were subjected to pathological
investigation to verify fatty dot or fatty streak lesions for-
mation. The entire aorta, from the aortic arch to the exter-
nal iliac arteries, was dissected out and cleaned of excess
adventitial tissue. The aortas were fixed in buffered 10%
formalin for 24 h, and then embedded in paraffin. The
paraffin-embedded specimens were sectioned at 5 μm (20
sections in succession) and stained with haematoxylin
and eosin, and examined by light microscopy to measure
fatty streak by two pathologists in a double-blinded man-
ner.
Fatty streak lesions were graded as zero for no fatty streak,
1 for existence of fatty streak in 1–4 sections, 2 for exist-
ence of fatty streak in 5–9 sections, 3 for existence of fatty
streak in 10–14 sections and 4 for existence of fatty streak
in 15 to all 20 sections of vessels.
In situ detection of apoptotic cells by TUNEL method
The Terminal deoxynucleotidyl Transferase Biotin-dUTP
Nick End Labeling (TUNEL) method was used for in situ
detection of apoptotic cells by in situ cell death detection
kit (Roche Applied Science, Indianopolis, IN, USA) as the
manufacturer's instructions. Breifly, after dewaxation of
formalin-fixed tissue sections; the slides were placed in a
plastic jar containing 200 ml 0.1 M citrate buffer, pH 6.0,
and were heated applying 350 W microwave irradiation
for 5 min. After rinsing the slide with PBS (20°–25°C),
they were immersed in a blocking solution containing 0.1
M Tris-HCl, 3% BSA, and 20% normal bovine serum, pH
7.5 for 30 min at room temperature, and washed again
with PBS. Then TUNEL reaction mixture was added and
incubated for 60 min at 37°C in a humidified chamber.
The slides were washed, and anti fluorescein conjugated
with alkaline phosphatase were added, and incubated
again for 30 min. After rinsing in PBS, BCIP-NBT substrate
solution was added and incubated for 15 min. The slides
were subjected to wash extensively in tap water and were
counterstained with hematoxylin. For apoptotic cells enu-
meration, at least 500 intimal cells were counted and the
number of apoptotic cells was determined per 500 cells
using light microscope.
Statistical Analysis
The data are reported as the mean ± SEM. A statistical soft-
ware package, SPSS (version 13), was used to perform sta-
tistical analysis. The data were tested for normality and
homogeneity of variance. Otherwise, unpaired Student's
t-test (equal or unequal variance assumed accordingly)
was used to assess the significance of any change between
groups. Statistical significance was accepted at p < 0.05.
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